Biologics in combination with nonbiologics: efficacy and safety.
- Published in:
- Dermatologic Therapy, 2004, v. 17, n. 5, p. 432, doi. 10.1111/j.1396-0296.2004.04046.x
- By:
- Publication type:
- Article
Works matching IS 13960296 AND DT 2004 AND VI 17 AND IP 5
Results: 10
1
2
Adalimumab: efficacy and safety in psoriasis and rheumatoid arthritis.
- Published in:
- Dermatologic Therapy, 2004, v. 17, n. 5, p. 427, doi. 10.1111/j.1396-0296.2004.04045.x
- By:
- Publication type:
- Article
3
Infliximab.
- Published in:
- Dermatologic Therapy, 2004, v. 17, n. 5, p. 409, doi. 10.1111/j.1396-0296.2004.04044.x
- By:
- Publication type:
- Article
4
Etanercept for the treatment of psoriasis and psoriatic arthritis.
- Published in:
- Dermatologic Therapy, 2004, v. 17, n. 5, p. 401, doi. 10.1111/j.1396-0296.2004.04043.x
- By:
- Publication type:
- Article
5
Efalizumab in the treatment of psoriasis.
- Published in:
- Dermatologic Therapy, 2004, v. 17, n. 5, p. 393, doi. 10.1111/j.1396-0296.2004.04042.x
- By:
- Publication type:
- Article
6
Alefacept: a review of the literature and practical guidelines for management.
- Published in:
- Dermatologic Therapy, 2004, v. 17, n. 5, p. 383, doi. 10.1111/j.1396-0296.2004.04041.x
- By:
- Publication type:
- Article
7
The promise and challenge of new biological treatments for psoriasis: how do they impact quality of life?
- Published in:
- Dermatologic Therapy, 2004, v. 17, n. 5, p. 376, doi. 10.1111/j.1396-0296.2004.04040.x
- By:
- Publication type:
- Article
8
Pediatric psoriasis and psoriatic arthritis.
- Published in:
- Dermatologic Therapy, 2004, v. 17, n. 5, p. 364, doi. 10.1111/j.1396-0296.2004.04039.x
- By:
- Publication type:
- Article
9
Psoriatic arthritis.
- Published in:
- Dermatologic Therapy, 2004, v. 17, n. 5, p. 350, doi. 10.1111/j.1396-0296.2004.04038.x
- By:
- Publication type:
- Article
10
Overview of psoriasis.
- Published in:
- Dermatologic Therapy, 2004, v. 17, n. 5, p. 341, doi. 10.1111/j.1396-0296.2004.04037.x
- By:
- Publication type:
- Article